ATE301453T1 - Injizierbare arzneiformulierungen von partricin derivaten - Google Patents
Injizierbare arzneiformulierungen von partricin derivatenInfo
- Publication number
- ATE301453T1 ATE301453T1 AT99914507T AT99914507T ATE301453T1 AT E301453 T1 ATE301453 T1 AT E301453T1 AT 99914507 T AT99914507 T AT 99914507T AT 99914507 T AT99914507 T AT 99914507T AT E301453 T1 ATE301453 T1 AT E301453T1
- Authority
- AT
- Austria
- Prior art keywords
- partricin
- derivatives
- medicinal formulations
- formulations
- injectable medicinal
- Prior art date
Links
- NVJUPMZQNWDHTL-MJODAWFJSA-N partricin Chemical class O1C(=O)CC(O)CC(=O)CC(O)CC(O)CC(O)CC(O)CC(O2)(O)CC(O)C(C(O)=O)C2CC(O[C@@H]2[C@@H]([C@H](N)[C@@H](O)[C@H](C)O2)O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C(C)C1C(C)CCC(O)CC(=O)C1=CC=C(N)C=C1 NVJUPMZQNWDHTL-MJODAWFJSA-N 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000003381 solubilizing effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
- Y10S977/797—Lipid particle
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
- Y10S977/797—Lipid particle
- Y10S977/798—Lipid particle having internalized material
- Y10S977/799—Containing biological material
- Y10S977/801—Drug
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/905—Specially adapted for travel through blood circulatory system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998MI001457A IT1301807B1 (it) | 1998-06-25 | 1998-06-25 | Formulazioni farmaceutiche iniettabili di derivati della partricina. |
| PCT/EP1999/001571 WO1999066902A1 (en) | 1998-06-25 | 1999-03-11 | Injectable pharmaceutical formulations of partricin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE301453T1 true ATE301453T1 (de) | 2005-08-15 |
Family
ID=11380320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99914507T ATE301453T1 (de) | 1998-06-25 | 1999-03-11 | Injizierbare arzneiformulierungen von partricin derivaten |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6586407B1 (enExample) |
| EP (1) | EP1089710B1 (enExample) |
| JP (1) | JP4719355B2 (enExample) |
| KR (1) | KR100622290B1 (enExample) |
| AT (1) | ATE301453T1 (enExample) |
| DE (1) | DE69926633T2 (enExample) |
| DK (1) | DK1089710T3 (enExample) |
| ES (1) | ES2245096T3 (enExample) |
| IT (1) | IT1301807B1 (enExample) |
| PT (1) | PT1089710E (enExample) |
| WO (1) | WO1999066902A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8658676B2 (en) | 2010-10-12 | 2014-02-25 | The Medicines Company | Clevidipine emulsion formulations containing antimicrobial agents |
| HUE026295T2 (en) | 2010-10-12 | 2016-06-28 | The Medicines Co | Clevidipine emulsion formulations containing antimicrobial agents |
| WO2019173526A1 (en) * | 2018-03-07 | 2019-09-12 | Andrew Xian Chen | Aqueous formulations for insoluble drugs |
| US20240317791A1 (en) * | 2021-07-12 | 2024-09-26 | Bioseutica B.V. | A process for the production of amcipatricin diascorbate and the use of the same for the treatment of invasive fungal infections resistant to traditional antifungal agents |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1359473A (en) * | 1970-11-03 | 1974-07-10 | Prodotti Antibiotici Spa | Polyenic antibiotic |
| GB1406774A (en) * | 1973-02-15 | 1975-09-17 | Prodotti Antibiotici Spa | Esters of patricin and of partricin derivatives |
| GB1413256A (en) * | 1973-05-14 | 1975-11-12 | Prodotti Antibiotici Spa | Water-solubilised antibiotics |
| GB1463348A (en) * | 1974-09-03 | 1977-02-02 | Prodotti Antibiotici Spa | Water-solubilised compositions |
| IE60901B1 (en) * | 1986-08-21 | 1994-08-24 | Vestar Inc | Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics |
| JP2653245B2 (ja) * | 1989-11-27 | 1997-09-17 | 日本新薬株式会社 | 脂肪乳剤 |
| JP2830243B2 (ja) * | 1989-12-21 | 1998-12-02 | 味の素株式会社 | ポリエン含有組成物 |
| IT1243404B (it) * | 1990-12-03 | 1994-06-10 | Prodotti Antibiotici Spa | Derivati della partricina |
| IT1283149B1 (it) * | 1996-07-12 | 1998-04-07 | Prodotti Antibiotici Spa | Complessi di n'-dimetilaminoacetilpartricina a dimetilaminoetilamide, o suoi sali, e colesterol 3-solfato |
-
1998
- 1998-06-25 IT IT1998MI001457A patent/IT1301807B1/it active IP Right Grant
-
1999
- 1999-03-11 PT PT99914507T patent/PT1089710E/pt unknown
- 1999-03-11 DK DK99914507T patent/DK1089710T3/da active
- 1999-03-11 DE DE69926633T patent/DE69926633T2/de not_active Expired - Lifetime
- 1999-03-11 EP EP99914507A patent/EP1089710B1/en not_active Expired - Lifetime
- 1999-03-11 US US09/720,236 patent/US6586407B1/en not_active Expired - Lifetime
- 1999-03-11 KR KR1020007014665A patent/KR100622290B1/ko not_active Expired - Fee Related
- 1999-03-11 JP JP2000555588A patent/JP4719355B2/ja not_active Expired - Fee Related
- 1999-03-11 ES ES99914507T patent/ES2245096T3/es not_active Expired - Lifetime
- 1999-03-11 WO PCT/EP1999/001571 patent/WO1999066902A1/en not_active Ceased
- 1999-03-11 AT AT99914507T patent/ATE301453T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI981457A1 (it) | 1999-12-25 |
| KR100622290B1 (ko) | 2006-09-11 |
| US6586407B1 (en) | 2003-07-01 |
| JP2002518431A (ja) | 2002-06-25 |
| IT1301807B1 (it) | 2000-07-07 |
| DK1089710T3 (da) | 2005-10-17 |
| PT1089710E (pt) | 2005-11-30 |
| DE69926633D1 (de) | 2005-09-15 |
| WO1999066902A8 (en) | 2001-02-15 |
| DE69926633T2 (de) | 2006-05-18 |
| KR20010071581A (enExample) | 2001-07-28 |
| JP4719355B2 (ja) | 2011-07-06 |
| EP1089710A1 (en) | 2001-04-11 |
| WO1999066902A1 (en) | 1999-12-29 |
| EP1089710B1 (en) | 2005-08-10 |
| ES2245096T3 (es) | 2005-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR037629A1 (es) | Formulaciones farmaceuticas que comprenden un derivado de platino | |
| TR200003158T2 (tr) | Jelleşebilen farmasötik bileşimler | |
| PT762896E (pt) | Composicoes de tocoferol para administracao de agentes biologicamente activos | |
| AR015598A1 (es) | FORMULACIoN LIOFILIZADA QUE COMPRENDE PROTEíNA C ACTIVADA, SU USO PARA LA PREPARACIoN DE UN MEDICAMENTO Y FORMA DE DOSIS UNITARIA QUE LA COMPRENDE. | |
| DE69919713D1 (de) | Pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung von phenytoin natrium | |
| DE69620606D1 (de) | Feste oral anzuwendende arzeneiform | |
| DE69809074D1 (de) | Herstellung von arzneimitteln | |
| EE05383B1 (et) | Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon | |
| BG103552A (bg) | Терапевтични средства | |
| BG60102B2 (bg) | Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол | |
| NZ501950A (en) | Medicinal compositions for application to mucosa | |
| YU2494A (sh) | Farmaceutska formulacija za tretiranje zavisnosti od nikotina | |
| ATE212351T1 (de) | Androsten-derivate | |
| BR9802537A (pt) | Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração | |
| ATE292453T1 (de) | Antivirale arznei | |
| NO20004419L (no) | Ny anvendelse | |
| NO994879D0 (no) | Stabiliserte humane papillomavirusformuleringer | |
| SE8804628D0 (sv) | New compounds | |
| ATE464878T1 (de) | Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl | |
| TR200100896T2 (tr) | İkameli propanol türevleri, imalat yöntemleri, bileşimleri içeren ilaçlar, kullanımları | |
| ATE301453T1 (de) | Injizierbare arzneiformulierungen von partricin derivaten | |
| ATE374600T1 (de) | Pharmazeutische formulierung enthaltend olanzapin | |
| CO4970832A1 (es) | Nuevas formulaciones y procesos para su fabricacion | |
| SE0001916D0 (sv) | Novel formulation | |
| GEP20022751B (en) | Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1089710 Country of ref document: EP |